Evaluation of an Emergency Obstetric and Neonatal Care (EmONC) Intervention Package to Reduce Adverse Pregnancy Outcomes in Low Resource Settings (The EmONC Trial)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Maternal Morbidity and Mortality
- Sponsor
- NICHD Global Network for Women's and Children's Health
- Enrollment
- 267181
- Locations
- 7
- Primary Endpoint
- Composite of either >28 week / >1000 gram stillbirth or 7 day neonatal mortality rate
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The objective of this cluster randomized controlled trial is to reduce maternal and neonatal mortality by increasing access to and improving the quality of obstetric and neonatal care for pregnant women in study clusters. It is hypothesized that a 25% reduction in >28 week or >1000 gram stillbirth and 7-day neonatal mortality will be achieved in the intervention clusters by a multifaceted Emergency Obstetric Neonatal Care (EmONC) package that will be introduced by an EmONC team.
Detailed Description
Maternal death, stillbirth, early neonatal death, and obstetric fistula are among the most devastating adverse outcomes of pregnancy. Existing interventions could avert the majority of maternal and neonatal deaths; however, those women at greatest risk are least likely to have access to interventions delivered through the formal health care system. In many developing countries, most deliveries in rural areas and a significant number in urban areas are conducted at home without skilled attendance, circumstances which pose a high risk for both mothers and their neonates. The EmONC trial is designed to evaluate a comprehensive intervention encompassing community mobilization to establish and sustain mechanisms of transport and payment and to drive client-oriented emergency obstetrical and neonatal care. The intervention includes teaching recognition of prolonged labor, infection, preeclampsia and hemorrhage, and the use of appropriate stabilization methods by all community birth attendants. In addition, poor access to quality emergency obstetric and neonatal care in a sustainable manner will be addressed. To evaluate the effectiveness of this approach, a cluster-randomized trial is required to assess whether Cluster EmONC teams can work with the community and health care system to reduce adverse pregnancy outcomes in diverse settings where the majority of deliveries occur at home or at a health clinic with few or no available EmONC interventions. To accomplish the intervention, a train-the-trainer approach will be used. Master trainers will facilitate central and regional training sessions for Country trainers organized around the areas of community mobilization; birth attendant skills; and EmONC referral facility improvements. The Country trainers will then support training and related activities in the intervention clusters, predominantly focusing on these three areas. The study population includes pregnant women (and their neonates) living and delivering in the 108 study clusters. The study clusters are largely rural, geographically distinct communities, each of which have approximately 300 annual deliveries. The women will be enrolled at or after 20 weeks gestation and followed to 42 days post delivery. The total duration of the trial will be 24 months.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pregnant women living in and/or delivering within the study cluster
- •Consent provided
Exclusion Criteria
- •Eligible pregnant women who do not consent
Outcomes
Primary Outcomes
Composite of either >28 week / >1000 gram stillbirth or 7 day neonatal mortality rate
Time Frame: 7 days post delivery
Secondary Outcomes
- 28-day neonatal mortality rate(28 days post delivery)
- Rates of mothers transported to a referral hospital.(42 days post delivery)
- Maternal morbidity rates(42 days post delivery)
- Stillbirth rate(Delivery)
- 7-day neonatal mortality rate(7 days post delivery)
- Rates of neonates/infants transported to a referral hospital(42 days post delivery)
- Maternal mortality rate(42 days post delivery)